PPH16: Mariam Moscovitch, MassGeneral Institute for Neurodegenerative Disease

Event Date

Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering Precision Health Summit 2016.